ChromoGenics AB announced that its order intake for the fourth quarter 2023 amounted to SEK 6.6 million and the order book for the same period was SEK 11.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 SEK | +6.58% | +8.97% | -2.86% |
04-02 | ChromoGenics AB Receives First Order for North America | CI |
03-08 | ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.86% | 4.16M | |
+19.28% | 15.32B | |
+30.36% | 7.94B | |
+14.48% | 2.57B | |
+22.09% | 823M | |
+1.25% | 411M | |
+2.64% | 357M | |
+7.51% | 233M | |
+14.62% | 198M | |
+4.86% | 165M |
- Stock Market
- Equities
- CHRO Stock
- News ChromoGenics AB
- ChromoGenics AB Communicates Order Intake for the Fourth Quarter 2023